Terms: = Endocrine gland cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Clinical Outcome
6 results:
1. ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.
Jung M; Gao J; Cheung L; Bongers A; Somers K; Clifton M; Ramsay EE; Russell AJ; Valli E; Gifford AJ; George J; Kennedy CJ; Wakefield MJ; Topp M; Ho GY; ; Scott CL; Bowtell DD; deFazio A; Norris MD; Haber M; Henderson MJ
Int J Cancer; 2020 Oct; 147(8):2225-2238. PubMed ID: 32277480
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic regulation affects n-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.
Angst E; Dawson DW; Nguyen A; Park J; Go VL; Reber HA; Hines OJ; Eibl G
Pancreas; 2010 Jul; 39(5):675-9. PubMed ID: 20173668
[TBL] [Abstract] [Full Text] [Related]
3. Eukaryotic initiation factor 4E staining as a clinical marker in pediatric neuroblastoma.
Parker A; Anderson C; Weiss KL; Grimley M; Sorrells D
J Pediatr Hematol Oncol; 2004 Aug; 26(8):484-7. PubMed ID: 15284584
[TBL] [Abstract] [Full Text] [Related]
4. Cystic neuroblastoma: emphasis on gene expression, morphology, and pathogenesis.
Kozakewich HP; Perez-Atayde AR; Donovan MJ; Fletcher JA; Estroff JA; Shamberger RC; Diller L
Pediatr Dev Pathol; 1998; 1(1):17-28. PubMed ID: 10463268
[TBL] [Abstract] [Full Text] [Related]
5. Bilateral adrenal neuroblastoma.
Zaizen Y; Suita S; Yamanaka K; Nagoshi M; Tsuda T
Eur J Pediatr Surg; 1997 Oct; 7(5):304-7. PubMed ID: 9402493
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of n-myc immunoreactivity in medullary thyroid carcinoma.
Roncalli M; Viale G; Grimelius L; Johansson H; Wilander E; Alfano RM; Springall D; Battezzati PM; Polak JM; Coggi G
Cancer; 1994 Jul; 74(1):134-41. PubMed ID: 7911734
[TBL] [Abstract] [Full Text] [Related]
